Merger Notification - Announcement according to § 10 Cartel Act
Dawaa'a Restricted Limited; Pharma Strategy Partners GmbH
BWB/Z-5758
On 12.11.2021 the Austrian Federal Competition Authority was notified of the following merger:
Planned purchase process
Acquisition of sole control over Pharma Strategy Partners GmbH, Switzerland which is the holding
company of the Swiss-based pharmaceutical manufacturer Acino International AG, indirectly by an
entity controlled by Abu Dhabi Developmental Holding Company PJSC, United Arab Emirates.
Affected industry: Contract manufacturing and outlicensing of pharmaceutical products for sale by
customers. Manufacture of basic pharmaceutical products.
Industry sector: C - Verarbeitendes Gewerbe/Herstellung von Waren
Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 10.12.2021.
Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.
Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.
Non-prohibition of the merger
The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 11.12.2021 .